- Trials with a EudraCT protocol (23)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
23 result(s) found for: Streptomyces.
Displaying page 1 of 2.
| EudraCT Number: 2008-005965-69 | Sponsor Protocol Number: VAMDAM-ED-08 | Start Date*: 2009-02-23 |
| Sponsor Name:Departamento de Microbiología. Hospital Clinico San Carlos | ||
| Full Title: Estudio piloto comparativo post-autorización de efectividad y seguridad, entre vancomicina y daptomicina, en las bacteriemias por Staphylococcus sp oxacilin-resistentes de los pacientes sometidos a... | ||
| Medical condition: Estudio comparativo del comportamiento de daptimicina y vancomicina en las bacteriemias por staphylococcus oxacilin-resistentes de pacientes sometidos a hemodialisis. valorando el tiempo hasta la n... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-005960-14 | Sponsor Protocol Number: VAMDAM-EH-08 | Start Date*: 2009-02-23 |
| Sponsor Name:Departamento de Microbiología. Hospital Clinico San Carlos | ||
| Full Title: Estudio piloto comparativo post-autorización de efectividad y seguridad, entre vancomicina y daptomicina, en las bacteriemias por Staphylococcus sp oxacilin-resistentes de los pacientes hematológicos. | ||
| Medical condition: Comparar el comportamiento entre daptomicina y vancomicina en las bacteriemias por staphylococcus oxacilin-resistentes(negativización del hemocultivo, complicaciones y efectos secundarios) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-005014-21 | Sponsor Protocol Number: DPI-tobra-kind | Start Date*: Information not available in EudraCT |
| Sponsor Name:University Medical Center Groningen | ||
| Full Title: Pharmacokinetic evaluation and tolerability of dry powder tobramycin via the Cyclops® in children with cystic fibrosis | ||
| Medical condition: Cystic Fibrosis Lung infections | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-000973-69 | Sponsor Protocol Number: 0468H1-318-WW | Start Date*: 2005-04-21 |
| Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc | ||
| Full Title: A Randomized, Open-Label, Comparative Evaluation of the Safety and Efficacy of Sirolimus versus Cyclosporine when Combined in a Regimen Containing Basiliximab, Mycophenolate Mofetil, and Corticoste... | ||
| Medical condition: The rationale for the present study is to assess whether a CNI-free regimen including antibody induction, sirolimus, and mycophenolate mofetil (MMF) results in improved long-term renal function wit... | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: HU (Completed) SE (Prematurely Ended) AT (Completed) GB (Completed) CZ (Prematurely Ended) ES (Completed) IT (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-004437-16 | Sponsor Protocol Number: tobra-02 | Start Date*: 2013-05-15 |
| Sponsor Name:University Medical Center Groningen | ||
| Full Title: Pharmacokinetic evaluation and tolerability of dry powder tobramycin by a novel device in patients with non cystic fibrosis bronchiectasis | ||
| Medical condition: Bronchiectasis Lung infections | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-007640-10 | Sponsor Protocol Number: J&P002/2007 | Start Date*: 2009-01-28 |
| Sponsor Name:PD Dr. med. K-H. Konz | ||
| Full Title: Tissue pharmacokinetics of daptomycin measured by in vivo microdialysis in patients with diabetic foot infection | ||
| Medical condition: A group of adult male or female patients with documented diabetes and bacterial soft tissue infection of the foot who must be subjected to undergo intravenous antimicrobial therapy with broad-spect... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-019712-20 | Sponsor Protocol Number: DCSP1 | Start Date*: Information not available in EudraCT |
| Sponsor Name:University of Oslo, Institute of Clinical Dentistry | ||
| Full Title: D-CYCLOSERINE ENHANCEMENT OF EXPOSURE TREATMENT OF DENTALLY FEARFUL AND AVOIDANT CHILDREN. A PILOT STUDY | ||
| Medical condition: Avoidance of dental care because of dental anxiety often result in reduced dental health and need for sedation or treatment in general anesthesia. Treatment of dental anxiety is time consuming and ... | ||
| Disease: | ||
| Population Age: Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NO (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-006949-75 | Sponsor Protocol Number: J&P005/2008 | Start Date*: 2009-08-13 |
| Sponsor Name:Medical University Graz, Department for Plastic Surgery | ||
| Full Title: Tissue pharmacokinetics of daptomycin measured by in vivo microdialysis in patients with diabetic foot infection | ||
| Medical condition: A group of adult male or female patients with documented diabetes and bacterial soft tissue infection of the foot who must be subjected to undergo intravenous antimicrobial therapy with broad spect... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-000935-27 | Sponsor Protocol Number: 0468H1-313-EU | Start Date*: 2005-06-15 |
| Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc.Clinical Research & Development Department | ||
| Full Title: A Randomized, Open-label, Comparative Evaluation of Conversion from Calcineurin Inhibitor Treatment to Sirolimus Treatment Versus Continued Calcineurin Inhibitor Treatment in Liver Allograft Recipi... | ||
| Medical condition: Liver allograft recipients under maintenance therapy | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: CZ (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-005399-15 | Sponsor Protocol Number: CEFFOS7 | Start Date*: 2010-03-10 |
| Sponsor Name:Medizinische Universität Graz - Abteilung für Thorax- und Hyperbare Chirurgie | ||
| Full Title: Penetration of Cubicin® and Fosfomycin® into skeletal muscle and subcutaneous adipose tissue of necrotizing soft tissue infections, measured by in-vivo microdialysis | ||
| Medical condition: A group of adult male or female patients with documented necrotizing soft tissue infection who must be subjected to undergo intravenous antimicrobial therapy with broad spectrum antibiotics. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-005594-29 | Sponsor Protocol Number: Moli1901-010 | Start Date*: 2006-10-31 |
| Sponsor Name:AOP Orphan Pharmaceuticals AG | ||
| Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Aerosolized Moli1901 in Adolescents (12 Years of Age or Older) and Adults with Cystic Fibrosis | ||
| Medical condition: Cystic Fibrosis | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: HU (Prematurely Ended) CZ (Prematurely Ended) SK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-001093-16 | Sponsor Protocol Number: DX203 | Start Date*: 2013-07-16 |
| Sponsor Name:Oculis ehf. | ||
| Full Title: Comparison of non-MMC trabeculectomy and dexamethasone nanoparticles eye drops with MMC trabeculectomy and Maxidex® | ||
| Medical condition: Anti-inflammatory treatment post trabeculectomy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: IS (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-012258-19 | Sponsor Protocol Number: F506-CL-0403 | Start Date*: 2011-03-09 | |||||||||||||||||||||
| Sponsor Name:Astellas Pharma Europe Ltd. | |||||||||||||||||||||||
| Full Title: A Multicentre, Open-label, Pharmacokinetic Study of Modigraf® (Tacrolimus granules) in de novo Paediatric Allograft Recipients.Estudio Abierto, Multicéntrico, Farmacocinético de Modigraf® (Tacróli... | |||||||||||||||||||||||
| Medical condition: De novo allograft transplantation (liver, heart, kidney) in paediatric patients. Pacientes pediátricos que reciben un trasplante de aloinjerto de novo ( hígado, corazón y riñón) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: ES (Completed) GB (Completed) DE (Completed) BE (Completed) FR (Ongoing) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2004-004884-31 | Sponsor Protocol Number: Nuth-2005-3400 | Start Date*: 2008-01-10 |
| Sponsor Name:Newcastle upon Tyne Hospitals NHS Trust | ||
| Full Title: An open label, randomized pilot study evaluating the early conversion from calcineurin inhibitors to Rapamune in patients with impaired renal function following kidney transplantation | ||
| Medical condition: This study will be conducted in 60 established renal allograft recipients who have suffered from chronic renal failure of any cause. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-012259-21 | Sponsor Protocol Number: F506-CL-0404 | Start Date*: 2011-03-02 | |||||||||||||||||||||
| Sponsor Name:Astellas Pharma Europe Ltd. | |||||||||||||||||||||||
| Full Title: A Long-term, Open-label, Non-comparative Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in Paediatric Solid Allograft Recipients.Estudio abierto, no compar... | |||||||||||||||||||||||
| Medical condition: Stable paediatric allograft recipients.Pacientes estables receptores de un aloinjerto | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: ES (Prematurely Ended) GB (Prematurely Ended) DE (Prematurely Ended) BE (Completed) FR (Prematurely Ended) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2017-000949-53 | Sponsor Protocol Number: OZBS62.14103 | Start Date*: 2017-06-16 | ||||||||||||||||
| Sponsor Name:Erasmus MC, Dept. Urology | ||||||||||||||||||
| Full Title: REduce BlAdder CAncer REcurrence in patients treated for upper urinary tract urothelial carcinoma (REBACARE Trial) | ||||||||||||||||||
| Medical condition: Upper Tract Urothelial Carcinoma (UTUC). | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2011-000493-56 | Sponsor Protocol Number: PIM4973g | Start Date*: 2011-09-15 | |||||||||||||||||||||
| Sponsor Name:GENENTECH, Inc. | |||||||||||||||||||||||
| Full Title: A PHASE II, OPEN-LABEL, RANDOMIZED STUDY OF GDC-0980 VERSUS EVEROLIMUS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA WHO HAVE PROGRESSED ON OR FOLLOWING VEGF-TARGETED THERAPY | |||||||||||||||||||||||
| Medical condition: METASTATIC RENAL CELL CARCINOMA | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: ES (Completed) DE (Completed) GB (Completed) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2006-002743-89 | Sponsor Protocol Number: S0106 | Start Date*: 2007-04-10 | |||||||||||
| Sponsor Name:Southwest Oncology Group (SWOG) | |||||||||||||
| Full Title: A PHASE III STUDY OF THE ADDITION OF GEMTUZUMAB OZOGAMICIN (MYLOTARG®) DURING INDUCTION THERAPY VERSUS STANDARD INDUCTION WITH DAUNOMYCIN AND CYTOSINE ARABINOSIDE FOLLOWED BY CONSOLIDATION AND SUBS... | |||||||||||||
| Medical condition: Previously untreated de novo acute myeloid leukemia | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-000306-46 | Sponsor Protocol Number: FG-506E-11-03 | Start Date*: 2004-07-16 |
| Sponsor Name:FUJISAWA | ||
| Full Title: A multicentre, 1:1 randomised, double blind, two arm parallel group study to evaluate and compare the efficacy and safety of modified release tacrolimus FK506E (MR4) versus tacrolimus FK506 in comb... | ||
| Medical condition: Liver transplantation | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: IT (Completed) FI (Completed) ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2018-001881-40 | Sponsor Protocol Number: BO40747 | Start Date*: 2018-11-27 | |||||||||||
| Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
| Full Title: A phase III, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Atezolizumab or placebo in combination with neoadjuvant doxorubicin + cyclophosphamid... | |||||||||||||
| Medical condition: Early Human epidermal growth factor receptor 2 (HER2)-positive breast cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) CZ (Completed) ES (Temporarily Halted) PL (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
